Immunomedics, Inc.
-
Ticker
IMMU
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Morris Plains, New Jersey
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe.
REPORT RATINGS
5.0 / 5.0 (2)
Immunomedics, Inc. reports have an aggregate usefulness score of 5.0 based on 2 reviews.
Immunomedics, Inc.
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Older/Archived Annual Reports